Dakota Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $725K | Buy |
1,380
+13
| +1% | +$6.83K | 0.02% | 446 |
|
|
2025
Q1 | $867K | Buy |
1,367
+1
| +0.1% | +$634 | 0.02% | 399 |
|
|
2024
Q4 | $973K | Buy |
1,366
+39
| +3% | +$27.8K | 0.02% | 369 |
|
|
2024
Q3 | $1.39M | Sell |
1,327
-67
| -5% | -$70.4K | 0.03% | 316 |
|
|
2024
Q2 | $1.47M | Buy |
1,394
+22
| +2% | +$23.1K | 0.03% | 301 |
|
|
2024
Q1 | $1.32M | Buy |
+1,372
| New | +$1.32M | 0.03% | 317 |
|
|
2021
Q1 | – | Sell |
-420
| Closed | -$203K | – | 342 |
|
|
2020
Q4 | $203K | Sell |
420
-14
| -3% | -$6.77K | 0.03% | 297 |
|
|
2020
Q3 | $243K | Sell |
434
-1
| -0.2% | -$560 | 0.04% | 239 |
|
|
2020
Q2 | $271K | Sell |
435
-114
| -21% | -$71K | 0.05% | 226 |
|
|
2020
Q1 | $268K | Buy |
+549
| New | +$268K | 0.06% | 209 |
|